Evolving landscape in the management of transthyretin amyloidosis
about
Transthyretin Cardiac Amyloidosis in Older Americans.Involvement of Macrophages in the Pathogenesis of Familial Amyloid Polyneuropathy and Efficacy of Human iPS Cell-Derived Macrophages in Its TreatmentPreclinical evaluation of RNAi as a treatment for transthyretin-mediated amyloidosis.Preclinical and Clinical Advances of GalNAc-Decorated Nucleic Acid Therapeutics.Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment.TTR kinetic stabilizers and TTR gene silencing: a new era in therapy for familial amyloidotic polyneuropathies.Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac Amyloidosis.The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market.Global epidemiology of transthyretin hereditary amyloid polyneuropathy: a systematic review.Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy.Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis.Emerging therapeutic targets currently under investigation for the treatment of systemic amyloidosis.Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm.Transthyretin Cardiac Amyloidosis in Older Adults: Optimizing Cardiac Imaging to the Corresponding Diagnostic and Management Goal.Evidence that glial cells attenuate G47R transthyretin accumulation in the central nervous system.Carpal Tunnel Biopsy Identifying Transthyretin Amyloidosis.Estimating the global prevalence of transthyretin familial amyloid polyneuropathy.Small Fiber Neuropathy: Disease Classification Beyond Pain and Burning.Wild-type transthyretin cardiac amyloidosis (ATTRwt-CA), previously known as senile cardiac amyloidosis: clinical presentation, diagnosis, management and emerging therapies.GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics
P2860
Q30244227-89519C3C-5446-466E-8F3D-E17A344C1FC6Q36151383-A190A088-FEE5-480C-9F04-A716AC390726Q36981555-269A07F1-04DE-49E4-BA96-9F70A1061446Q37718173-286038B3-8C36-4518-B445-700EA281A8B9Q38663987-0DA1190C-5105-4556-A362-154414085951Q38708201-8125D40A-2AE8-423B-9D58-6DD9A8FE8253Q39217713-46A92986-50E0-4777-96EC-ACA38CA9812BQ39227810-1F6AC5A7-04B9-47D8-A2E7-0ED3DB67C668Q39257021-9893FA23-24AA-4A51-88CE-BF6F01CC17D4Q41282445-D8A1A6E3-71DE-4070-A838-53DC9A1ED783Q47128372-FCE4C329-3CC4-4D18-A512-F37BFC98E93FQ47404960-D1251CBD-213C-4C14-9B49-CF8159DE32EEQ47561760-291AED13-211D-47E6-960A-286705FC3A9AQ47637174-0A397428-5752-4A28-8F99-DE24C734C9ABQ47727255-D2426BF4-B9FB-4963-86E5-B4DC6C595823Q48361513-210E9D0C-E2EF-46CE-ADEC-00B1A436BEE8Q50049023-E1B9FDC6-615F-44CE-993F-632029525FC4Q55310742-A2DAE1DE-710D-4F41-94D0-3C5FF2CC5621Q55425790-43C17972-12E9-4DF5-9FE3-515855DFE2DFQ57094579-30A01ACF-D0BB-4541-9B08-52FDC2823783
P2860
Evolving landscape in the management of transthyretin amyloidosis
description
2015 nî lūn-bûn
@nan
2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Evolving landscape in the management of transthyretin amyloidosis
@ast
Evolving landscape in the management of transthyretin amyloidosis
@en
Evolving landscape in the management of transthyretin amyloidosis
@nl
type
label
Evolving landscape in the management of transthyretin amyloidosis
@ast
Evolving landscape in the management of transthyretin amyloidosis
@en
Evolving landscape in the management of transthyretin amyloidosis
@nl
prefLabel
Evolving landscape in the management of transthyretin amyloidosis
@ast
Evolving landscape in the management of transthyretin amyloidosis
@en
Evolving landscape in the management of transthyretin amyloidosis
@nl
P2093
P2860
P50
P3181
P1433
P1476
Evolving landscape in the management of transthyretin amyloidosis
@en
P2093
Alejandra Gonzalez-Duarte
Angela Dispenzeri
Philip N Hawkins
P2860
P304
P3181
P356
10.3109/07853890.2015.1068949
P407
P577
2015-01-01T00:00:00Z
2015-11-27T00:00:00Z